Industry Categories Biotechnology

Biotechnology, Healthcare

Healthcare Innovation Report July 2026: Capital Concentration, AI Ubiquity, and the GLP-1 Supply Chain Fuel Industry Resurgence

Digital tablet displaying healthcare market analytics and medical models in a clinical setting.

NEW YORK, NY — August 3, 2026 (ACI Newswire) – The healthcare technology and biopharmaceutical sectors exited the first half of 2026 with a material rebound in venture funding and a sharper focus on manufacturing infrastructure, driven by high-conviction investments in…

ACINews
September 25, 2026

Biotechnology

Precision Medicine and Pharmacogenomics Redefine the Global Standard of Care

Medical researcher analyzing genomic sequencing data for personalized healthcare solutions.

NEW YORK, NY — September 3, 2026 (ACI Newswire) – The transition toward personalized healthcare solutions is accelerating across the global medical sector as healthcare systems steadily transition away from traditional one-size-fits-all treatment models. Driven by expanding applications in pharmacogenomics, artificial…

ACINews
September 3, 2026

Biotechnology

AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease

AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson’s Disease Grant supports extension of Part 1 of Phase 2 VacSYn trial of ACI-7104 Planned extension of Part 1 will assess long-term safety and efficacy…

ACINews
June 11, 2026

Biotechnology

CDD Vault and Kiin Bio Integrate to Streamline End-to-End Drug Discovery Workflows

LONDON, UNITED KINGDOM, June 11, 2026 — Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, and Kiin Bio, a pioneer in AI-native Drug Discovery platform, today announced a strategic partnership…

ACINews
June 11, 2026

Biotechnology

Lunai Bioworks & BrainStorm Therapeutics Launch Foundation-Funded Parkinson’s & Rare Epilepsy AI Discovery Collaboration

SACRAMENTO, CA, UNITED STATES, May 28, 2026 — Collaboration integrates AI discovery, human brain organoid modeling, and in vivo validation to generate differentiated neurology assets for pharmaceutical partnering and development Lunai Bioworks’ (NASDAQ: LNAI) wholly owned subsidiary BioSymetrics and…

ACINews
May 28, 2026